title: Biomedical and Market Issues Surrounding the Advent of Biosimilars.
abstract: As the patents associated with the biologics are set to expire in the near future, a new type of therapy appears on the horizon, and it is quite similar to the biologics. This commentary examines the biomedical and market issues surrounding the advent of biosimilars.
authors.affiliation: Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA, 30912, USA.
authors.forename: Abigail
authors.initials: A
authors.lastname: Cline
authors.affiliation: Division of Dermatology, Department of Medicine, Augusta University, Augusta, GA, USA. JakeTurrentine@gmail.com.
authors.forename: Jake E
authors.initials: JE
authors.lastname: Turrentine
keywords: Biologics; Biosimilars; Inflectra; Infliximab; Interchangeable; Psoriasis; Remsima